The effect of L-arginine and ascorbic acid on the visceral fat and the concentrations of metalloproteinases 2 and 9 in high-fat-diet rats

Endokrynologia Polska

Volumn 66, Issue 6, 2015, Pages 526-532

  Kujawska Luczak, Magdalena ^a   Suliburska, Joanna ^b   Markuszewski, Leszek ^c   Pupek Musialik, Danuta ^a   Jabecka, Anna ^a   Bogdañski, Pawe ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b POZNA UNIVERSITY OF LIFE SCIENCES   (Poland)

^c POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

High fat diet; L arginin; Metaloproteinases; Rats; Visceral fat

Indexed keywords

ARGININE; ASCORBIC ACID; GELATINASE A; GELATINASE B; GLUCOSE; INSULIN; MMP2 PROTEIN, HUMAN; MMP9 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIPID DIET; MALE; NONHUMAN; RAT; ANIMAL; DIETARY SUPPLEMENT; DRUG EFFECTS; GENE EXPRESSION; GENETICS; METABOLISM; WISTAR RAT;

ANIMALS; ARGININE; ASCORBIC ACID; DIET, HIGH-FAT; DIETARY SUPPLEMENTS; FEMALE; GENE EXPRESSION; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; RATS; RATS, WISTAR;

EID: 84949751269     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: 10.5603/EP.2015.0065     Document Type: Article

References (42)

1. van Harmelen V, Skurk T, Röhrig K et al. Effect of BMI and age on adipose tissue cellularity and differentiation capacity in women. Int J Obes Relat Metab Disord 2003; 27: 889-895. doi:10.1038/sj.ijo.0802314.
2. Chavey C, Mari B, Monthouel et al. Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation. J Biol Chem 2003; 278: 11888-11896. doi: 10.1074/jbc. M209196200.
3. Bourboulia D, Stetler-Stevenson WG. Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion. Semin Cancer Biol 2010; 20: 161-168. doi: 10.1016/j.semcancer.2010.05.002.
4. Brown LM, Fox HL, Hazen SA et al. Role of the matrixin MMP-2 in mul-ticellular organization of adipocytes cultured in basement membrane components. Am J Physiol 1997; 272: C937-949.
5. Lijnen HR, Maquoi E, Holvoet P et al. Adipose tissue expression of gelati-nases in mouse models of obesity. Thromb Haemost 2001; 85: 1111-1116.
6. Dubois SG, Tchoukalova YD, Heilbronn LK et al. Look AHEAD Adipose Research Group. Potential role of increased matrix metalloproteinase-2 (MMP2) transcription in impaired adipogenesis in type 2 diabetes mel-litus. Biochem Biophys Res Commun 2008; 367: 725-728. doi: 10.1016/j. bbrc.2007.12.180.
7. Amalinei C, Caruntu ID, Balan RA. Biology of metalloproteinases. Rom J Morphol Embryol 2007; 48: 323-334.
8. Derosa G, Ferrari I, D'Angelo A et al. Matrix metalloproteinase-2 and-9 levels in obese patients. Endothelium 2008; 15: 219-224. doi: 10.1080/10623320802228815.
9. Lijnen HR, Maquoi E, Hansen LB et al. Matrix metalloproteinase inhibition impairs adipose tissue development in mice. Arterioscler Thromb Vasc Biol 2002; 22: 374-379. doi: 10.1161/hq0302.104522.
10. Derosa G, D'Angelo A, Scalise F et al. Comparison between metallopro-teinases-2 and-9 in healthy subjects, diabetics, and subjects with acute coronary syndrome. Heart Vessels 2007; 22: 361-370.
11. Derosa G, Cicero A F, Scalise F et al. Metalloproteinase-2 and-9 in diabetic and nondiabetic subjects during acute coronary syndromes. Endothelium 2007; 14: 45-51.
12. Derosa G, Maffoli P, D'Angelo A et al. Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in combined dyslipidemia. Clin Invest Med 2009; 32: E124-132.
13. Bogdanski P, Szulinska M, Suliburska J et al. Supplementation with L-arginine favorably infuences plasminogen activator inhibitor type 1 concentration in obese patients. A randomized, double blind trial. J Endocrinol Invest 2013; 36: 221-226. doi: 10.3275/8467.
14. Fu WJ, Haynes TE, Kohli R et al. Dietary L-arginine supplementation reduces fat mass in Zucker diabetic fatty rats. J Nutr 2005; 135: 714-721. doi: 10.3945/jn.108.096362.
15. Jobgen W, Meininger CJ, Jobgen SC et al. Dietary L-arginine supplementation reduces white fat gain and enhances skeletal muscle and brown fat masses in diet-induced obese rats. J Nutr 2009; 139: 230-237.
16. Du J, Cullen JJ, Buettner GR. Ascorbic acid: chemistry, biology and the treatment of cancer. Biochim Biophys Acta 2012; 1826: 443-457. doi: 10.1016/j.bbcan.2012.06.003.
17. Mikirova N, Casciari J, Rogers A et al. Effect of high-dose intravenous vitamin C on infammation in cancer patients. J Transl Med 2012; 10: 189. doi: 10.1186/1479-5876-10-189. doi: 10.1186/1479-5876-10-189.
18. Reeves PG. Components of the AIN-93 diets as improvements in the AIN-76A diet. J Nutr 1997; 127 (5 Suppl.): 838S-841S.
19. Wu G, Collins JK, Perkins-Veazie P et al. Dietary supplementation with watermelon pomace juice enhances arginine availability and ameliorates the metabolic syndrome in Zucker diabetic fatty rats. J Nutr 2007; 137: 2680-2685.
20. Jobgen W, Fu WJ, Gao H et al. High fat feeding and dietary L-arginine supplementation differentially regulate gene expression in rat white adipose tissue. Amino AIDS 2009; 37: 187-198. doi: 10.1007/s00726-009-0246-7.
21. Demeulemeester D, Collen D, Lijnen HR. Effect of matrix metallopro-teinase inhibition on adipose tissue development. Biochem Biophys Res Commun 2005; 329: 105-110. doi:10.1016/j.bbrc.2005.01.103.
22. Van Hul M, Lupu F, Dresselaers T et al. Matrix metalloproteinase inhibition affects adipose tissue mass in obese mice. Clin Exp Pharmacol Physiol 2012; 39: 544-550. doi: 10.1111/j.1440-1681.2012.05714.x.
23. Van Hul M, Bauters D, Lijnen RH. Differential effects of a gelatinase inhibitor on adipocyte differentiation and adipose tissue development. Clin Exp Pharmacol Physiol 2013; 40: 689-697. doi: 10.1111/1440-1681.12154.
24. Alam MA, Kauter K, Withers K et al. Chronic l-arginine treatment improves metabolic, cardiovascular and liver complications in diet-induced obesity in rats. Food Funct 2013; 4: 83-91. doi: 10.1039/c2fo30096f.
25. Kraus H, Bogdanski P, Sosnowski P et al. Influence of short-term L-arginine supplementation on carbohydrate balance in rats with ischemia-reperfusion syndrome. Pharmacol Rep 2012; 64: 635-642.
26. Tsuchiya K, Sakai H, Suzuki N et al. Chronic blockade of nitric oxide synthesis reduces adiposity and improves insulin resistance in high fat-induced obese mice. Endocrinology 2007; 148: 4548-5456. doi: http://dx.doi.org/10.1210/en.2006-1371.
27. Boden G, Song W, Pashko L et al. In vivo effects of insulin and free fatty acids on matrix metalloproteinases in rat aorta. Diabetes 2008; 57: 476-483. doi: 10.2337/db07-1261.
28. Monti LD, Galluccio E, Lucotti P et al. Benefcial role of L-arginine in cardiac matrix remodeling in insulin resistant rats. Eur J Clin Invest 2008; 38: 849-856. doi: 10.1111/j.1365-2362.2008.02027.x.
29. Campión J, Milagro FI, Fernández D et al. Vitamin C supplementation infuences body fat mass and steroidogenesis-related genes when fed a high-fat diet. Int J Vitam Nutr Res 2008; 78: 87-95. doi: 10.1024/0300-9831.78.2.87.
30. Thornton SJ, Wong I T, Neumann R et al. Dietary supplementation with phytosterol and ascorbic acid reduces body mass accumulation and alters food transit time in a diet-induced obesity mouse model. Lipids Health Dis 2011; 10: 107-120. doi: 10.1186/1476-511X-10-107.
31. Orbe J, Rodríguez JA, Arias R et al. Antioxidant vitamins increase the collagen content and reduce MMP-1 in a porcine model of atherosclerosis: implications for plaque stabilization. Atherosclerosis 2003; 167: 45-53. doi: http://dx.doi.org/10.1016/S0021-9150(02)00392-1.
32. Fisher GJ, Quan T, Purohit T et al. Collagen fragmentation promotes oxidative stress and elevates matrix metalloproteinase-1 in fbroblasts in aged human skin. Am J Pathol 2009; 174: 101-114. doi: 10.2353//ajpath.2009.080599.
33. Fan X, Xiaoqin L, Potts B et al. Topical application of L-arginine blocks advanced glycation by ascorbic acid in the lens of hSVCT2 transgenic mice. Mol Vis 2011; 17: 2221-2227.
34. Chen HH, Wang DL. Nitric oxide inhibits matrix metalloproteinase-2 expression via the induction of activating transcription factor 3 in endothe-lial cells. Mol Pharmacol 2004; 65: 1130-1140. doi: 10.1124/mol.65.5.1130.
35. Garanich JS, Pahakis M, Tarbell JM. Shear stress inhibits smooth muscle cell migration via nitric oxide-mediated downregulation of matrix metalloproteinase-2 activity. Am J Physiol Heart Circ Physiol 2005; 288: H2244-2252.doi: 10.1152/ajpheart.00428.2003.
36. Pustovrh MC, Jawerbaum A, White V et al. The role of nitric oxide on matrix metalloproteinase 2 (MMP2) and MMP9 in placenta and fetus from diabetic rats. Reproduction 2007; 134: 605-613. doi: 10.1530/REP-06-0267.
37. Novaro V, Colman-Lerner A, Ortega FV et al. Regulation of metallopro-teinases by nitric oxide in human trophoblast cells in culture. Reprod Fertil Dev 2001; 13: 411-420. doi:10.1071/RD01036.
38. Hale SA, Weger L, Mandala M et al. Reduced NO signaling during pregnancy attenuates outward uterine artery remodeling by altering MMP expression and collagen and elastin deposition. Am J Physiol Heart Circ Physiol 2011; 301: H1266-1275. doi: 10.1152/ajpheart.00519.2011.
39. Robinson EK, Kelly D P, Mercer DW et al. Differential effects of lu-minal arginine and glutamine on metalloproteinase production in the postischemic gut. J Parenter Enteral Nutr 2008; 32: 33-38. doi: 10.1177/0148607108319806.
40. Lewinski A, Brona A, Lewandowski K et al. In contrast to matrix metalloproteinases, serum adiponectin concentrations increase after radioiodine treatment of thyrotoxicosis. Thyroid Res 2012; 5: 12. doi: 10.1186/1756-6614-5-12.
41. Yao XM, Ye SD, Zai Z et al. Simvastatin protects diabetic rats against kidney injury through the suppression of renal matrix metalloprotein-ase-9 expression. J Endocrinol Invest 2010; 33: 292-296. doi: 10.3275/6558.
42. Mysliwiec J, Adamczyk M, Pawłowski P et al. Serum gelatinases (MMP-2 and MMP-9) and VCAM-1 as a guideline in a therapeutic approach in Graves' ophthalmopathy. Endokrynol Pol 2007; 58: 105-109.